MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
0.7290
+0.0111
+1.55%
After Hours: 0.7396 +0.0106 +1.45% 19:48 02/18 EST
OPEN
0.7301
PREV CLOSE
0.7179
HIGH
0.7599
LOW
0.7217
VOLUME
4.40M
TURNOVER
--
52 WEEK HIGH
2.105
52 WEEK LOW
0.6404
MARKET CAP
212.37M
P/E (TTM)
-4.2882
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OCGN last week (0210-0214)?
Weekly Report · 1d ago
Buy Rating for Ocugen Based on Promising OCU410 Study Progress and Geographic Atrophy Treatment Potential
TipRanks · 4d ago
Ocugen Inc. Stock Advances 6.5%, Outperforms Market
Dow Jones · 5d ago
Analysts Offer Insights on Healthcare Companies: Ocugen (OCGN) and Xilio Therapeutics (XLO)
TipRanks · 5d ago
Ocugen Is Maintained at Buy by Chardan Capital
Dow Jones · 5d ago
Ocugen Price Target Maintained With a $6.00/Share by Chardan Capital
Dow Jones · 5d ago
Chardan Capital Maintains Buy on Ocugen, Maintains $6 Price Target
Benzinga · 5d ago
Expert Outlook: Ocugen Through The Eyes Of 4 Analysts
Benzinga · 5d ago
More
About OCGN
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.